Back to GetFilings.com



Table of Contents



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

(Mark One)

     
(X)    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
    For the quarterly period ended June 29, 2002
    or
     
( )    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

Commission file number: 0-27892

SIPEX Corporation
(Exact Name of Registrant as Specified in its Charter)

     
Massachusetts   04-6135748
(State or Other Jurisdiction of   (I.R.S. Employer
Incorporation or Organization)   Identification No.)
      
22 Linnell Circle, Billerica, Massachusetts   01821
(Address of principal executive offices)   (Zip Code)

(978) 667-8700
Registrant’s telephone number, including area code



Former name, former address and former fiscal year if changed since last report.

         Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes (X)  No ( ) 

         There were 27,955,682 shares of the Registrant’s Common Stock issued and outstanding as of August 2, 2002.




TABLE OF CONTENTS

Part I: FINANCIAL INFORMATION
Item 1: Financial Statements CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk:
Part II: OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds:
Item 4. Submission of Matters to a Vote of Security Holders
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
AMEND AND RESTATED CREDIT AGREEMENT
EX-99.1 CERTIFICATION OF CEO
EX-99.2 CERTIFICATION OF CFO


Table of Contents

FORM 10-Q
THREE MONTHS ENDED JUNE 29, 2002

INDEX

                 
Item            
Number       Page

     
PART I:  
FINANCIAL INFORMATION
       
Item 1.  
Financial Statements
       
       
Condensed Consolidated Balance Sheets at June 29, 2002 and December 31, 2001
    3  
       
Condensed Consolidated Statements of Operations for the three and six month periods ended June 29, 2002 and June 30, 2001
    4  
       
Condensed Consolidated Statements of Cash Flows for the six month periods ended June 29, 2002 and June 30, 2001
    5  
       
Notes To Condensed Consolidated Financial Statements
    6-8  
Item 2.  
Management’s Discussion and Analysis of Financial Condition and Results of Operations
    9-20  
Item 3.  
Quantitative and Qualitative Disclosure about Market Risk
    20  
PART II:  
OTHER INFORMATION
       
Item 1.  
Legal Proceedings
    21  
Item 2.  
Changes in Securities and Use of Proceeds
    21  
Item 3.  
Defaults Upon Senior Securities
    *  
Item 4.  
Submission of Matters to a Vote of Security Holders
    21  
Item 5.  
Other Information
    *  
Item 6.  
Exhibits and Reports on Form 8-K
    21  
       
SIGNATURES
    22  

* No information provided due to inapplicability of item.

2


Table of Contents

Part I: FINANCIAL INFORMATION
Item 1: Financial Statements

SIPEX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)

                       
          June 29,   December 31,
          2002   2001
         
 
          (Unaudited)   (Audited)
ASSETS:
               
Current Assets:
               
 
Cash and cash equivalents
  $ 5,426     $ 4,874  
   
Short-term investment securities
    5,961        
   
Accounts receivable, less allowances of $982 and $2,444 at June 29, 2002 and December 31, 2001, respectively
    11,952       10,966  
 
Inventories
    25,691       25,295  
 
Deferred income taxes-current
          3,163  
 
Prepaid expenses and other current assets
    1,902       1,871  
 
   
     
 
     
Total current assets
    50,932       46,169  
Property, plant, and equipment, net
    65,823       67,172  
Goodwill
          2,984  
Deferred income taxes
          28,688  
Other assets
    114       114  
 
   
     
 
     
Total assets
  $ 116,869     $ 145,127  
 
   
     
 
LIABILITIES AND SHAREHOLDERS’ EQUITY:
               
Current Liabilities:
               
 
Accounts payable
  $ 10,378     $ 5,989  
 
Accrued expenses
    4,130       2,928  
 
Deferred income
    819       992  
 
   
     
 
     
Total current liabilities
    15,327       9,909  
Long-term debt
          7,396  
 
   
     
 
     
Total liabilities
    15,327       17,305  
 
   
     
 
Shareholders’ equity:
               
 
Preferred stock, $.01 par value, 1,000 shares authorized and no shares issued or outstanding at June 29, 2002 and December 31, 2001, respectively
           
 
Common stock, $.01 par value, 40,000 shares authorized and 27,954 and 24,844 shares issued and outstanding at June 29, 2002 and December 31, 2001, respectively
    279       248  
 
Additional paid-in capital
    173,642       149,447  
 
Accumulated deficit
    (72,353 )     (21,903 )
 
Accumulated other comprehensive income (loss)
    (26 )     30  
 
   
     
 
     
Total shareholders’ equity
    101,542       127,822  
 
   
     
 
     
Total liabilities and shareholders’ equity
  $ 116,869     $ 145,127  
 
   
     
 

See accompanying notes to condensed consolidated financial statements

3


Table of Contents

SIPEX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

                                     
        Three Months Ended   Six Months Ended
       
 
        June 29,   June 30,   June 29,   June 30,
        2002   2001   2002   2001
       
 
 
 
Net sales
  $ 16,988     $ 19,372     $ 33,052     $ 39,066  
Cost of sales
    18,931       21,671       32,820       40,468  
 
   
     
     
     
 
 
Gross profit (loss)
    (1,943 )     (2,299 )     232       (1,402 )
 
   
     
     
     
 
Operating expenses
                               
 
Research and development
    3,560       3,514       6,274       7,559  
 
Marketing and selling
    2,206       2,628       4,472       5,287  
 
General and administrative
    2,645       1,914       4,300       3,993  
 
Restructuring and facility exit costs
          494             177  
 
Amortization/impairment of goodwill
    2,984       94       2,984       188  
 
   
     
     
     
 
   
Total operating expenses
    11,395       8,644       18,030       17,204  
 
   
     
     
     
 
(Loss) from operations
    (13,388 )     (10,943 )     (17,798 )     (18,606 )
Other income (expense), net
    (329 )     (112 )     (716 )     28  
 
   
     
     
     
 
(Loss) before income taxes
    (13,667 )     (11,055 )     (18,514 )     (18,578 )
Income tax expense (benefit)
    33,826       (4,750 )     31,936       (7,245 )
 
   
     
     
     
 
Net (loss)
  $ (47,493 )   $ (6,305 )   $ (50,450 )   $ (11,333 )
 
   
     
     
     
 
Net (loss) per common share-basic and assuming dilution
  $ (1.70 )   $ (0.26 )   $ (1.91 )   $ (0.49 )
 
   
     
     
     
 
Weighted average common and common equivalent shares outstanding-basic and assuming dilution
    27,930       23,983       26,402       23,248  
 
   
     
     
     
 

See accompanying notes to condensed consolidated financial statements

4


Table of Contents

SIPEX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

                         
            Six Months Ended
           
            June 29,   June 30,
            2002   2001
           
 
Operating activities:
               
 
Net (loss)
  $ (50,450 )   $ (11,333 )
 
Adjustments to reconcile net (loss) to net cash used in operating activities:
               
     
(Increase) decrease in deferred income taxes
    31,851       (7,248 )
     
Provision for uncollectable receivables and returns and allowances
    713       1,803  
     
Depreciation and amortization
    7,203       3,795  
     
Change in other long-term liabilities
          (1,396 )
     
Changes in current assets and liabilities:
               
       
(Increase) decrease in accounts receivable
    (1,699 )     3,079  
       
Increase in inventories
    (396 )     (575 )
       
Increase in prepaid expenses and other assets
    (31 )     (703 )
       
Increase (decrease) in accounts payable
    4,389       (2,660 )
       
Increase (decrease) in accrued expenses
    1,202       (302 )
       
(Decrease) increase in deferred income
    (173 )     310  
 
   
     
 
       
     Net cash used in operating activities
    (7,391 )     (15,230 )
 
   
     
 
Investing activities:
               
   
Proceeds from restricted cash
          36,750  
   
Purchase of investments
    (5,961 )      
   
Purchase of property, plant and equipment
    (2,870 )     (38,232 )
 
   
     
 
       
     Net cash used in investing activities
    (8,831 )     (1,482 )
 
   
     
 
Financing activities:
               
   
Proceeds from issuance of common stock
    24,226       22,112  
   
(Payments of) proceeds from debt obligations
    (7,396 )     136  
 
   
     
 
       
     Net cash provided by financing activities
    16,830       22,248  
 
   
     
 
Effect of foreign currency translation adjustments
    (56 )     (53 )
 
   
     
 
Increase in cash and cash equivalents
    552       5,483  
Cash and cash equivalents, beginning of period
    4,874       1,732  
 
   
     
 
Cash and cash equivalents, end of period
  $ 5,426     $ 7,215  
 
   
     
 
Supplemental cash flow information:
               
   
Cash paid during the period for:
               
     
Income taxes
  $ 81     $  
     
Interest
  $ 12     $ 360  

See accompanying notes to condensed consolidated financial statements

5


Table of Contents

SIPEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. Basis of Presentation

         The consolidated financial statements include the accounts of Sipex Corporation (the “Company”) and all of its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.

         The accompanying unaudited financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2001, included in the Company’s Form 10-K filing. The accompanying financial statements reflect all adjustments (consisting solely of normal, recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of results for the interim periods presented and were prepared based upon the accounting policies disclosed in the Company’s Form 10-K. The results of operations for the three and six month periods ended June 29, 2002 are not necessarily indicative of the results to be expected for the full fiscal year.

2. Significant Accounting Policies

         Recent Accounting Pronouncements

         The FASB issued SFAS No. 145, “Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections,” effective for fiscal years beginning May 15, 2002 or later that rescinds FASB Statement No. 4, Reporting Gains and Losses from Extinguishment of Debt, FASB Statement No. 64, Extinguishments of Debt Made to Satisfy Sinking-Fund Requirements, and FASB Statement No. 44, Accounting for Intangible Assets of Motor Carriers. This Statement amends FASB Statement No. 4 and FASB Statement No. 13, Accounting for Leases, to eliminate an inconsistency between the required accounting for sale-leaseback transactions. This Statement also amends other existing authoritative pronouncements to make various technical corrections, clarify meanings or describe their applicability under changed conditions. We are currently examining the effect of this pronouncement on the results of operations and financial position of Sipex, but currently we believe the effect will not be material.

         On July 30, 2002, the FASB issued Statement No. 146, “Accounting for Costs Associated with Exit or Disposal Activities”. Statement No. 146 is based on the fundamental principle that a liability for a cost associated with an exit or disposal activity should be recorded when it (1) is incurred, that is, when it meets the definition of a liability in FASB Concepts Statement No. 6, “Elements of Financial Statements", and (2) can be measured at fair value. The principal reason for issuing Statement 146 is the Board’s belief that some liabilities for costs associated with exit or disposal activities that entities record under current accounting pronouncements, in particular Issue 94-3, do not meet the definition of a liability. Statement 146 nullifies Issue 94-3; thus, it will have a significant effect on practice because commitment to an exit or disposal plan no longer will be a sufficient basis for recording a liability for costs related to those activities. Statement No.146 is effective for exit and disposal activities initiated after December 31, 2002. Early application is encouraged; however, previously issued financial statements may not be restated. An entity would continue to apply the provisions of Issue 94-3 to an exit activity that it initiated under an exit plan that met the criteria of Issue 94-3 before the entity initially applied Statement 146. We are currently examining the effect of this pronouncement on the results of operations and financial position of Sipex, but currently we believe the effect will not be material.

3. Goodwill Impairment

         For the quarter ended March 30, 2002, the Company adopted SFAS 142 effective and was no longer amortizing goodwill upon adoption, thereby eliminating annual goodwill amortization of approximately $376,000. Upon adoption of SFAS 142 on January 1, 2002, the Company performed a goodwill impairment test and concluded that there was no indication of impairment and recorded no impairment at January 1, 2002.

6


Table of Contents

         In the second quarter of 2002, the Company experienced significant changed circumstances resulting from the Company’s stock price decreasing during the quarter, which reduced the Company’s fair value. These circumstances indicated that the Company’s goodwill might not be recoverable. As a result, the Company performed a goodwill impairment test in accordance with SFAS 142. The results of the impairment test indicated that the full amount of the Company’s goodwill of $3.0 million was not recoverable and was written off. The impairment charge in the second quarter of 2002 compared with the quarterly goodwill amortization of $94,000 during 2001 under SFAS 121.

         The proforma effects of the adoption of SFAS 142 on net income and earnings per share for the Company for the three and six months ended June 30, 2001 is as follows (in thousands):

                 
Three Months Ended Six Months Ended
June 29, 2002 June 29, 2002


Net (loss) as reported $ (6,305 ) $ (11,333 )
Add back: Goodwill amortization expense 94 188


Adjusted net (loss) $ (6,211 ) $ (11,145 )


Basic and diluted (loss) per share, as reported $ (0.26 ) $ (0.49 )
Add back: Goodwill amortization expense 0.01


Proforma basic loss per share $ (0.26 ) $ (0.48 )


4. Long-term Debt

         On April 16, 2002, the outstanding bank line of credit balance of $6.9 million was paid down to zero using proceeds from the private placement of Company common stock (see Note 8). The line of credit has a borrowing limit of $10.0 million with a borrowing base of 80% of the Company’s accounts receivable. Funds advanced under the line bear interest at the bank’s base rate minus 0.5%, are due June 1, 2003 and are collateralized by substantially all our assets. For the quarter ended June 29, 2002, the Company was not in compliance with the net income, quick ratio and current ratio covenants on its bank line of credit and has obtained a waiver from the lender as of June 29, 2002, as well as an amendment to the net income requirements for the third and fourth quarter of 2002 and the quick ratio and current ratio requirements through June 1, 2003.

5. Net Income (Loss) Per Share

         Net income (loss) per share-basic is based upon the weighted average number of common shares outstanding. Net income (loss) per share assuming dilution is based upon the weighted average number of common and common equivalent shares outstanding assuming dilution. Common equivalent shares, consisting of outstanding stock options, are included in the per share calculations where the effect of their inclusion would be dilutive.

         A reconciliation of basic weighted average common shares with weighted average shares assuming dilution is as follows (in thousands):

                                 
                     
    Three Months Ended   Six Months Ended
   
 
    June 29,   June 30,   June 29,   June 30,
    2002   2001   2002   2001
   
 
 
 
Weighted average shares — basic
    27,930       23,983       26,402       23,248  
Net effect of dilutive potential common shares outstanding based on the Treasury stock method using the average market price
                       
 
   
     
     
     
 
Weighted average common shares assuming dilution
    27,930       23,983       26,402